Try our beta test site
Trial record 1 of 21 for:    cantos
Previous Study | Return to List | Next Study

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) (CANTOS)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: March 29, 2011
Last updated: December 7, 2016
Last verified: December 2016